This study continues surveillance of more than 200 of the most commonly prescribed drugs for carcinogenicity, and examines selected drug-cancer associations of potential importance.
Pharmaceuticals and Cancer
Investigator: Habel, Laurel
Funder: Kaiser Permanente Institutional Planned Giving